Assessment of efficacy and safety of PEG-IFN alpha-2a administration into patients with chronic hepatitis B on nuleoside analogue
Not Applicable
Recruiting
- Conditions
- Chronic hepatitis B
- Registration Number
- JPRN-UMIN000015633
- Lead Sponsor
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Defense Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with advance liver fibrosis 2. Patients with other serious diseases 3. Women who are pregnant or those who have a possibility to be pregnant. 4. Patients who have a contra-indication for receiving PEG-IFN alpha-2a treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method